QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2020    专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Pharmacokinetics, mass balance, and metabolism of [C-14]vicagrel, a novel irreversible P2Y(12) inhibitor in humans 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 12 作者:  Zheng, Yuan-dong;  Zhang, Hua;  Zhan, Yan;  Bian, Yi-cong;  Ma, Sheng 收藏  |  浏览/下载：44/0  |  提交时间：2021/05/24 vicagrel  [C-14]vicagrel  vicagrel pharmacokinetics  vicagrel metabolism  mass balance  P2Y(12) receptor inhibitor   In Silico Screening-Based Discovery of Novel Inhibitors of Human Cyclic GMP-AMP Synthase: A Cross-Validation Study of Molecular Docking and Experimental Testing 期刊论文 JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 卷号: 60, 期号: 6, 页码: 3265-3276 作者:  Zhao, Wenfeng;  Xiong, Muya;  Yuan, Xiaojing;  Li, Minjun;  Sun, Hongbin 收藏  |  浏览/下载：20/0  |  提交时间：2020/12/24 Tricarabrols A-C, three anti-inflammatory sesquiterpene lactone trimers featuring a methylene-tethered linkage from Carpesium faberi 期刊论文 ORGANIC CHEMISTRY FRONTIERS, 2020, 卷号: 7, 期号: 11, 页码: 1374-1382 作者:  Yuan, Jie;  Wen, Xuelan;  Ke, Chang-Qiang;  Zhang, Tian;  Lin, Ligen 收藏  |  浏览/下载：25/0  |  提交时间：2020/12/24 Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 卷号: 28, 期号: 7, 页码: 10 作者:  Min, Wenjian;  Hou, Zeng;  Zhang, Fang;  Xie, Shengnan;  Yuan, Kai 收藏  |  浏览/下载：56/0  |  提交时间：2020/07/01 Histone methylation  Lysine methyltransferase  SET7  Small-molecule inhibitor  Virtual screening   Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 1, 页码: 129-137 作者:  Liao, Xiao-ying;  Deng, Qiang-qiang;  Han, Li;  Wu, Zhi-tao;  Peng, Zhao-liang 收藏  |  浏览/下载：59/0  |  提交时间：2020/07/01 leflunomide  teriflunomide  acyclovir  organic anion transporter  multidrug resistance associated protein (MRP) 2  drug-drug interaction  pharmacokinetics